Search Count: 9
 |
Erap1 In Complex With 1-[2-(5-Bromo-7-Fluoro-2-Oxo-2,3-Dihydro-1,3-Benzothiazol-3-Yl)Acetamido]-4,4-Difluorocyclohexane-1-Carboxylic Acid
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.55 Å Release Date: 2026-05-06 Classification: PEPTIDE BINDING PROTEIN Ligands: ZN, SIN, PO4, EDO, A1JVE |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2026-05-06
Ligands: ZN, SIN, PO4, EDO, A1JVE
 |
Erap1 In Complex With 1-[2-(6-Bromo-2,2-Difluoro-3-Oxo-3,4-Dihydro-2H-1,4-Benzoxazin-4-Yl)Acetamido]Cyclohexane-1-Carboxylic Acid
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.57 Å Release Date: 2026-04-22 Classification: PEPTIDE BINDING PROTEIN Ligands: ZN, PO4, EDO, A1JVD |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2026-04-22
Ligands: ZN, PO4, EDO, A1JVD
 |
Erap1 In Complex With 1-[2-(2-Oxo-5-Phenyl-2,3-Dihydro-1,3-Benzoxazol-3-Yl)Acetamido]Cyclohexane-1-Carboxylic Acid
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.73 Å Release Date: 2026-04-22 Classification: PEPTIDE BINDING PROTEIN Ligands: ZN, MLT, EDO, A1JVG |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2026-04-22
Ligands: ZN, MLT, EDO, A1JVG
 |
Erap1 In Complex With 1-[2-(5-Chloro-2-Oxo-2,3-Dihydro-1,3-Benzothiazol-3-Yl)Acetamido]Cyclohexane-1-Carboxylic Acid
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.45 Å Release Date: 2026-04-22 Classification: PEPTIDE BINDING PROTEIN Ligands: ZN, PO4, EDO, A1JVH |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2026-04-22
Ligands: ZN, PO4, EDO, A1JVH
 |
Erap1 In Complex With 1-[2-(3-Oxo-6-Phenyl-3,4-Dihydro-2H-1,4-Benzoxazin-4-Yl)Acetamido]Cyclohexane-1-Carboxylic Acid
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.37 Å Release Date: 2026-04-22 Classification: PEPTIDE BINDING PROTEIN Ligands: ZN, PO4, EDO, A1JVF |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2026-04-22
Ligands: ZN, PO4, EDO, A1JVF
 |
Pi3 Kinase Delta In Complex With 5-[3,6-Dihydro-2H-Pyran-4-Yl]-2-Methoxy-N-[2-Methylpyridin-4-Yl]Pyridine-3-Sulfonamide
Organism: Mus musculus
Method: X-RAY DIFFRACTION Resolution:2.49 Å Release Date: 2021-09-29 Classification: SIGNALING PROTEIN Ligands: 7VT |
Organism: Mus musculus
Method: X-RAY DIFFRACTION
Release Date: 2021-09-29
Ligands: 7VT
 |
Pi3 Kinase Delta In Complex With N-[2-(2-Fluoro-4-{[4-(Propan-2-Yl)Piperazin-1-Yl]Methyl}Phenyl)Pyridin-4-Yl]-2-Methoxy-5-(Morpholin-4-Yl)Pyridine-3-Sulfonamide
Organism: Mus musculus
Method: X-RAY DIFFRACTION Resolution:2.26 Å Release Date: 2021-09-29 Classification: SIGNALING PROTEIN Ligands: 7XH |
Organism: Mus musculus
Method: X-RAY DIFFRACTION
Release Date: 2021-09-29
Ligands: 7XH
 |
Pi3 Kinase Delta In Complex With 5-(3,6-Dihydro-2H-Pyran-4-Yl)-2-Methoxy-N-(5-{3-[4-(Propan-2-Yl)Piperazin-1-Yl]Prop-1-Yn-1-Yl}Pyridin-3-Yl)Pyridine-3-Sulfonamide
Organism: Mus musculus
Method: X-RAY DIFFRACTION Resolution:2.49 Å Release Date: 2021-09-29 Classification: SIGNALING PROTEIN Ligands: 7XN |
Organism: Mus musculus
Method: X-RAY DIFFRACTION
Release Date: 2021-09-29
Ligands: 7XN
 |
Pi3 Kinase Delta In Complex With N-[5-(3,6-Dihydro-2H-Pyran-4-Yl)-2-Methoxypyridin-3-Yl]Benzenesulfonamide
Organism: Mus musculus
Method: X-RAY DIFFRACTION Resolution:2.39 Å Release Date: 2021-09-29 Classification: SIGNALING PROTEIN Ligands: 7XW |
Organism: Mus musculus
Method: X-RAY DIFFRACTION
Release Date: 2021-09-29
Ligands: 7XW